CellWell record HH-274100
Chimeric antigen receptor therapy in infectious diseases: emerging applications with a focus on invasive fungal infections
Carme Bracke; Ignacio Grafia; Pedro Puerta-Alcalde
2026
In plain language
CAR-engineered immune cells targeting fungal cell wall β-glucans and mannans show promising preclinical antifungal activity against Aspergillus and Candida.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-274100
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.